IntegenX Inc. has secured $40 Million in Series C funding to accelerate development of the company's product pipeline and the commercialization of its RapidHIT 200 Human Identification System into domestic and international markets. Industry observers expect this product to be disruptive and that it will create a new market for rapid analysis of human DNA…
Bringing together companies who power secure identification to promote the use of hardware-based security.